Does METOPROLOL Cause Cerebral hypoperfusion? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Cerebral hypoperfusion have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.0% of all adverse event reports for METOPROLOL.
6
Reports of Cerebral hypoperfusion with METOPROLOL
0.0%
of all METOPROLOL reports
3
Deaths
6
Hospitalizations
How Dangerous Is Cerebral hypoperfusion From METOPROLOL?
Of the 6 reports, 3 (50.0%) resulted in death, 6 (100.0%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Cerebral hypoperfusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Cerebral hypoperfusion?
FUROSEMIDE (48)
CARBIDOPA\LEVODOPA (44)
RIVAROXABAN (44)
METFORMIN (43)
AMITRIPTYLINE (42)
APOMORPHINE (42)
ATORVASTATIN (42)
BISACODYL (42)
DOMPERIDONE (42)
HUMAN IMMUNOGLOBULIN G (42)
Which METOPROLOL Alternatives Have Lower Cerebral hypoperfusion Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE